Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163823 · ClinicalTrials.gov registry record · NA
CTSI-iPad for Vented Patient Communication
A NA study of Respiratory Failure, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03163823: Completed NA study of Respiratory Failure, sponsored by Medical College of Wisconsin.
NCT03163823 is a NA study of Respiratory Failure that has completed, run by Medical College of Wisconsin. The registered enrollment target is 21 participants, below the 4,523-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03163823, a NA study of Respiratory Failure, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll 75 mechanically vented adults in the ICU to compare self-reported ease of communication, patient satisfaction, and patient anxiety and frustration levels between a group using a communication application on an iPad and a group using standard methods of communication while mechanically vented.
Primary Outcome
Patient self-reported ease of communication during mechanical ventilation measured using a Likert scale
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Proloquo2Go
Study Locations (1)
Wisconsin
- Froedtert Memorial Lutheran Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-02-23 |
| Est. Completion | 2020-09-21 |
| Phase | NA |
What the finished NCT03163823 record still lists
NCT03163823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 4,523-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03163823 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03163823 about?
NCT03163823 is a clinical study titled "CTSI-iPad for Vented Patient Communication". This study will enroll 75 mechanically vented adults in the ICU to compare self-reported ease of communication, patient satisfaction, and patient anxiety and frustration levels between a group using a communication application on an iPad and a group using standard methods of communication while mech...
What is the current status of trial NCT03163823?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-02-23. Estimated completion is 2020-09-21.
What conditions does trial NCT03163823 study?
This clinical trial studies the following conditions: Respiratory Failure.
What interventions are being tested in trial NCT03163823?
The interventions under investigation include: Standard of Care (OTHER), Proloquo2Go (OTHER).
Who is sponsoring clinical trial NCT03163823?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03163823 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03163823's enrollment target sits among peer trials
21 35th of 40 higher than 6 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI